Why is Indo US Bio-Tech falling/rising?

As of 23-Sep, Indo US Bio-Tech Ltd's stock price is currently at Rs 138.15, reflecting a decrease of Rs 3.2 or 2.26%. The stock has been underperforming, having fallen consecutively over the last two days, resulting in a total decline of 3.83%. It is also trading close to its 52-week low, just 0.4% away from Rs 137.6. The stock has shown significant underperformance over various periods, with a year-to-date decline of 56.14% and a one-year return of -52.03%, compared to the Sensex's positive return of 5.07%. Despite the company's strong fundamentals, including a high return on capital employed (ROCE) of 25.53% and consistent profit growth, the stock's price continues to decline, indicating a disconnect between its financial performance and market perception. In the broader market context, Indo US Bio-Tech's recent performance has been notably weaker than the benchmark, with a one-week return of -3.43% compared to the Sensex's -0.34%. This underperformance is compounded by a significant drop in investor participation, as evidenced by a 79.7% decrease in delivery volume compared to the five-day average. The stock's liquidity remains adequate for trading, but the persistent decline and negative sentiment may be contributing to its struggles in the market. Overall, while the company has demonstrated strong operational metrics, the market's reaction has been unfavorable, leading to the current downward trend in its stock price.